Molecular Instruments, Inc.
Los Angeles, CA
- UEI
- SP8PV4N4ZED9
- CAGE
- 88XN3
- Primary NAICS
- 459999 All Other Miscellaneous Retailers
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5015 Eagle Rock Blvd #301, Los Angeles, CA 90041, USA
- Website
- molecularinstruments.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | -$414 |
| FY2026 | -$5 |
| FY2025 | $14,690 |
| FY2024 | -$1 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
About the company
Molecular Instruments, Inc. is a for-profit corporate entity specializing in the development and manufacturing of advanced scientific instruments and probes for biological research and imaging technologies. Based in Los Angeles, California, the company is registered in SAM.gov and focuses on creating sophisticated scientific equipment used primarily in biomedical research settings. The company produces specialized scientific products such as Hybridization Chain Reaction (HCR) amplifiers and probe sets, targeting research institutions and laboratories with cutting-edge molecular imaging technologies.
Through federal contract awards, Molecular Instruments, Inc. has predominantly secured small purchase order contracts with various National Institutes of Health (NIH) institutes, including the National Institute of Child Health and Human Development (NICHD), National Institute of Dental and Craniofacial Research, and the National Institute on Deafness and Other Communication Disorders. These contracts, typically ranging from $10,000 to $20,000, involve supplying scientific instruments like HCR amplifiers and probe sets. The contracts have been awarded without specific set-aside designations, indicating the company competes in open federal procurement processes. The purchase orders are primarily firm fixed-price contracts with completion dates spanning from 2021 to 2025.
Molecular Instruments, Inc. has been highly successful in securing federal grant awards, particularly from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program. The company has received multiple project grants totaling significant funding to advance probe technologies for RNA imaging. These grants focus on developing advanced technologies for ultrasensitive, multiplex RNA and protein imaging, with specific research goals including quantitative signal amplification, digital and analog mRNA quantitation, and automatic background suppression. The grant projects aim to overcome long-standing technological limitations in biological research by creating innovative imaging methods that enable more comprehensive and precise molecular imaging techniques across various biological samples, including whole-mount vertebrate embryos, thick brain slices, and formalin-fixed paraffin-embedded (FFPE) tissue sections.
Quick answers
Is Molecular Instruments, Inc. registered in SAM.gov?
Yes. Molecular Instruments, Inc.'s SAM.gov registration is active through October 10, 2027.
What is Molecular Instruments, Inc.'s CAGE code?
Molecular Instruments, Inc.'s CAGE code is 88XN3, and its Unique Entity ID (UEI) is SP8PV4N4ZED9.
How much has Molecular Instruments, Inc. received in federal contracts?
Federal contracts obligated $14,690 to Molecular Instruments, Inc. in fiscal year 2025 and $14,271 in fiscal years 2023 through 2027.
How does Molecular Instruments, Inc. rank among federal contractors?
Molecular Instruments, Inc. ranked #10 in NAICS 45999, #20 in NAICS 4599 and #45 in NAICS 459 in FY2025.
What is Molecular Instruments, Inc.'s most recent federal award?
Molecular Instruments, Inc.'s most recent federal grant award is Advancing probe technology for ultrasensitive RNA imaging via hybridization chain reaction (R43GM163490), from National Institute of General Medical Sciences (NIH), on September 30, 2025.
On GovTribe
See Molecular Instruments, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors